Characterization, treatment and prognosis of retinoblastoma with central nervous system metastasis
Author:
Funder
Beijing Key Laboratory of Intraocular Tumor Diagnosis and Treatment
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology,General Medicine
Link
http://link.springer.com/content/pdf/10.1186/s12886-018-0772-8.pdf
Reference23 articles.
1. Kivelä T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 2009;93:1129–31.
2. Abramson DH, Schefler AC. Update on retinoblastoma. Retina. 2004;24:828–48.
3. Temming P, Lohmann D, Bornfeld N, Sauerwein W, Goericke SL, Eggert A. Current concepts for diagnosis and treatment of retinoblastoma in Germany: aiming for safe tumor control and vision preservation. Klin Padiatr. 2012;224:339–47.
4. Huang D, Zhang Y, Zhang W, Wang Y, Zhang P, Hong L, Zhou Y, Han T, Zhi T. Study on clinical therapeutic effect including symptoms, eye preservation rate, and follow-up of 684 children with retinoblastoma. Eur J Ophthalmol. 2013;23:532–8.
5. Dimaras H, Kimani K, Dimba EA, Gronsdahl P, White A, Chan HS, Gallie BL. Retinoblastoma. Lancet. 2012;379:1436–46.
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Management of Extraocular Retinoblastoma: ICMR Consensus Guidelines;Indian Journal of Pediatrics;2024-04-19
2. Metastatic retinoblastoma at presentation: Clinical presentation, treatment, and outcomes;Oman Journal of Ophthalmology;2023-09
3. Oncogenic Proteomics Approaches for Translational Research and HIV-Associated Malignancy Mechanisms;Proteomes;2023-07-04
4. Piperlongumine inhibits proliferation and oncogenic MYCN expression in chemoresistant metastatic retinoblastoma cells directly and through extracellular vesicles;Biomedicine & Pharmacotherapy;2023-05
5. miR-4529-3p Promotes the Progression of Retinoblastoma by Inhibiting RB1 Expression and Activating the ERK Signaling Pathway;Molecular Biotechnology;2023-04-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3